The store will not work correctly when cookies are disabled.
6-oxo-7,8,9,10-tetrahydro-6H-benzo[c]chromen-3-yl dihydrogen phosphate
ID: ALA4576206
PubChem CID: 129868496
Max Phase: Preclinical
Molecular Formula: C13H13O6P
Molecular Weight: 296.22
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: O=c1oc2cc(OP(=O)(O)O)ccc2c2c1CCCC2
Standard InChI: InChI=1S/C13H13O6P/c14-13-11-4-2-1-3-9(11)10-6-5-8(7-12(10)18-13)19-20(15,16)17/h5-7H,1-4H2,(H2,15,16,17)
Standard InChI Key: GIIDGDLHNDDUGS-UHFFFAOYSA-N
Molfile:
RDKit 2D
20 22 0 0 0 0 0 0 0 0999 V2000
28.7915 -23.5087 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
28.3871 -22.8029 0.0000 P 0 0 0 0 0 0 0 0 0 0 0 0
27.9781 -23.5061 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
23.4427 -24.0081 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.4427 -24.8253 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.1479 -25.2297 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.1479 -23.5954 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.8532 -24.0081 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.8497 -24.8253 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.5518 -25.2346 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.2618 -24.8313 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
25.5587 -23.6002 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.2610 -24.0141 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.9685 -23.6129 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.9749 -22.7980 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.2679 -22.3860 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.5633 -22.7895 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.5472 -26.0518 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
27.6850 -22.3936 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
29.1004 -22.4020 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 2 1 0
4 5 1 0
4 7 1 0
5 6 1 0
6 9 1 0
8 7 1 0
8 9 2 0
8 12 1 0
9 10 1 0
10 11 1 0
11 13 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 12 1 0
10 18 2 0
15 19 1 0
19 2 1 0
2 20 2 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 296.22 | Molecular Weight (Monoisotopic): 296.0450 | AlogP: 2.14 | #Rotatable Bonds: 2 |
Polar Surface Area: 96.97 | Molecular Species: ACID | HBA: 4 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 1.78 | CX Basic pKa: ┄ | CX LogP: 1.95 | CX LogD: -1.17 |
Aromatic Rings: 2 | Heavy Atoms: 20 | QED Weighted: 0.65 | Np Likeness Score: 0.40 |
References
1. Saha T, Makar S, Swetha R, Gutti G, Singh SK.. (2019) Estrogen signaling: An emanating therapeutic target for breast cancer treatment., 177 [PMID:31129450] [10.1016/j.ejmech.2019.05.023] |